Microduplications on chromosome 14q11.2 including the FOXG1 gene have been reported in patients with developmental delay, cognitive impairment with speech delay, and epilepsy.1, 2 Such association has been confirmed subsequently in other patients.3, 4 However, Amor et al5 have found an ∼88 kb duplication at 14q12, encompassing the FOXG1 and C14orf23 genes in a father-son pair with isolated hemifacial microsomia. Neither the son nor the father exhibited mental retardation or epilepsy. They also identified an ∼3 Mb duplication of the 14q12 region, including FOXG1, in a child enrolled as a control subject in the CHOP CNV database6 and questioned the pathogenicity of FOXG1 duplication.
We believe it is important to highlight that the clinical phenotypes observed in the seven patients in the original description of the syndrome include a relatively wide spectrum of neurodevelopmental abnormalities, ranging from mild to severe intellectual disability and variable presence of epilepsy (in four out of the seven patients).1 Thus, it is not surprising that subjects at the mildest end of the spectrum may present with few or no clinically evident manifestations of the disease.
Moreover, the duplicated copy of FOXG1 reported by Amor et al5 is small and may be devoid of its distant regulatory elements, which may explain the lack of neurocognitive phenotype. In support of this notion, two other FOX genes, FOXF1 and FOXL2, encoding for the evolutionarily conserved family of transcription factors with a central role in development have been shown recently to be upregulated by non-coding copy-number variants mapping over 250 kb 5′ from these genes.7, 8 Of note, FOXG1 expression is restricted to the brain, and thus more likely to be finely regulated by such distant enhancer(s) in a tissue-specific manner.
With regard to the individual in the CHOP CNV database with a FOXG1 duplication, we agree with the authors’ suggestion that the CHOP subject with the duplication of FOXG1 may have not manifested yet the neurodevelopmental abnormalities.
On the basis of the well-established causative role of genomic deletions and point mutations of FOXG1 in determining a Rett-like phenotype9, 10 and the studies generated in animal models,11 the evidence of FOXG1 as a dosage sensitive gene is compelling. Thus, we believe microduplications involving FOXG1 should not be considered of questionable pathogenicity but rather highly likely to be pathogenic, albeit associated with a wide spectrum of abnormalities, which is commonly observed with other microduplication syndromes.12
References
Brunetti-Pierri N, Paciorkowski AR, Ciccone R et al: Duplications of FOXG1 in 14q12 are associated with developmental epilepsy, mental retardation, and severe speech impairment. Eur J Hum Genet 2011; 19: 102–107.
Yeung A, Bruno D, Scheffer IE et al: 4.45 Mb microduplication in chromosome band 14q12 including FOXG1 in a girl with refractory epilepsy and intellectual impairment. Eur J Med Genet 2009; 52: 440–442.
Striano P, Paravidino R, Sicca F et al: West syndrome associated with 14q12 duplications harboring FOXG1. Neurology 2011; 76: 1600–1602.
Tohyama J, Yamamoto T, Hosoki K et al: West syndrome associated with mosaic duplication of FOXG1 in a patient with maternal uniparental disomy of chromosome 14. Am J Med Genet A 2011; 155A: 2584–2588.
Amor DJ, Burgess T, Tan TY, Pertile M : Questionable pathogenicity of FOXG1 duplication. Eur J Hum Genet 2012; e-pub ahead of print 18 January 2012; doi:10.1038/ejhg.2011.267.
Shaikh TH, Gai X, Perin JC et al: High-resolution mapping and analysis of copy number variations in the human genome: a data resource for clinical and research applications. Genome Res 2009; 19: 1682–1690.
Stankiewicz P, Sen P, Bhatt SS et al: Genomic and genic deletions of the FOX gene cluster on 16q24.1 and inactivating mutations of FOXF1 cause alveolar capillary dysplasia and other malformations. Am J Hum Genet 2009; 84: 780–791.
D’haene B, Attanasio C, Beysen D et al: Disease-causing 7.4 kb Cis-regulatory deletion disrupting conserved non-coding sequences and their interaction with the FOXL2 promotor: implications for mutation screening. PLoS Genet 2009; 5: e1000522.
Ariani F, Hayek G, Rondinella D et al: FOXG1 is responsible for the congenital variant of Rett syndrome. Am J Hum Genet 2008; 83: 89–93.
Jacob FD, Ramaswamy V, Andersen J, Bolduc FV : Atypical Rett syndrome with selective FOXG1 deletion detected by comparative genomic hybridization: case report and review of literature. Eur J Hum Gene 2009; 17: 1577–1581.
Xuan S, Baptista CA, Balas G, Tao W, Soares VC, Lai E : Winged helix transcription factor BF-1 is essential for the development of the cerebral hemispheres. Neuron 1995; 14: 1141–1152.
Stankiewicz P, Pursley AN, Cheung SW : Challenges in clinical interpretation of microduplications detected by array CGH analysis. Am J Med Genet A 2010; 152A: 1089–1100.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
Drs Cheung and Stankiewicz are based in the Department of Molecular and Human Genetics at Baylor College of Medicine (BCM), which offers genetic laboratory testing, including use of arrays for genomic copy number analysis, and derives revenue from this activity.
Rights and permissions
About this article
Cite this article
Brunetti-Pierri, N., Cheung, S. & Stankiewicz, P. Reply to Amor et al. Eur J Hum Genet 20, 597 (2012). https://doi.org/10.1038/ejhg.2011.270
Published:
Issue Date:
DOI: https://doi.org/10.1038/ejhg.2011.270
This article is cited by
-
Do regulatory regions matter in FOXG1 duplications?
European Journal of Human Genetics (2013)
-
14q12 and severe Rett-like phenotypes: new clinical insights and physical mapping of FOXG1-regulatory elements
European Journal of Human Genetics (2012)